Novelle Bio GLP-1

Description

Semaglutide is a synthetic peptide research compound acting at the glucagon-like peptide-1 (GLP-1) receptor. It is used as a reference incretin-pathway agonist in metabolic studies.

Non-clinical research in cultured cells and animal models has examined glucose control, insulin output, appetite-linked behavior, and GLP-1 receptor signaling. Its single defined target makes it a clean comparator for incretin-focused work.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.